Phase I study of SB-480848(darapladib) -Repeat dose study in healthy Japanese male subjects-, Trial ID LPL110736

Phase I study of SB-480848(darapladib) -Repeat dose study in healthy Japanese male subjects-, Trial ID LPL110736 | GSK